PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40643499,Effects of Mesenchymal Stem Cells on Functions of Chimeric Antigen Receptor-Expressing T Lymphocytes and Natural Killer Cells.,2025 Jun 25,"Harrell, Carl Randall","Regenerative Processing Plant, LLC, 34176 US Highway 19 N, Palm Harbor, FL 34684, USA.",Not found
40638673,Contributing to a value-based health care framework for lung cancer patients in Switzerland - A methodological approach to merge routinely collected hospital data.,2025,"Pletscher, Flurina; Kasenda, Benjamin; Finazzi, Tobias","Roche Pharma (Schweiz) AG, Basel, Switzerland.; Roche Pharma (Schweiz) AG, Basel, Switzerland.; Roche Pharma (Schweiz) AG, Basel, Switzerland.",Not found
40631774,First-in-human phase I open-label study of the LAG-3 antagonist antibody INCAGN02385 in patients with select advanced or metastatic solid tumors.,2025 Jul 4,"Hoyle, Paul E; Dong, Zhiwan; Cheng, Lulu; Chen, Xuejun; Janik, John E; Bourayou, Nawel","Incyte Corporation, Wilmington, DE 19803, United States.; Incyte Corporation, Wilmington, DE 19803, United States.; Incyte Corporation, Wilmington, DE 19803, United States.; Incyte Corporation, Wilmington, DE 19803, United States.; Incyte Corporation, Wilmington, DE 19803, United States.; Incyte Biosciences International Sarl, 1110 Morges, Switzerland.",Not found
40631773,First-in-human phase I open-label study of the anti-TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors.,2025 Jul 4,"Hoyle, Paul E; Dong, Zhiwan; Cheng, Lulu; Gong, Xiaohua; Janik, John E; Bourayou, Nawel","Incyte Corporation, Wilmington, DE 19803, USA.; Incyte Corporation, Wilmington, DE 19803, USA.; Incyte Corporation, Wilmington, DE 19803, USA.; Incyte Corporation, Wilmington, DE 19803, USA.; Incyte Corporation, Wilmington, DE 19803, USA.; Incyte Biosciences International Sarl, 1110 Morges, Switzerland.",Not found
